retatrutide phase 2 study results just delivered the first top-line 3 for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Let's talk about a new

GLP-1 receptor agonists are medications that copy this hormones effects

Regular blood tests to check kidney and pancreatic function can help detect problems early

In vivo studies Although improving the proteolytic protection or the plasmatic stability of some hybrids represented a significant milestone, the most important question remained: are those improvements reflected in vivo

[137] [138] High demand caused worldwide supply shortages of semaglutide in 2023

In addition to its effects on appetite and weight loss, Semaglutide GLP-1 also stimulates the production of insulin in response to food intake, which helps to lower blood sugar levels

This effect has limited the use and production of GIP analogues as they may potentiate the diabetogenic glucagon effect through augmented gluconeogenesis and glycogenolysis